For citations:
Klimov A.V., Karyakin A.O., Drobot N.Ts., Gazaryan E.O., Kabardaev R.M., Valiev A.K., Matveev V.B., Averianova S.V. Combination of lenvatinib and pembrolizumab in treatment of patients with metastatic renal cell carcinoma and factors of poor prognosis. Cancer Urology. 2025;21(2):145-152. (In Russ.) https://doi.org/10.17650/1726-9776-2025-21-2-145-152
Email this article 